A detailed history of Torren Management, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Torren Management, LLC holds 42 shares of INVA stock, worth $934. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42
Holding current value
$934
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 29, 2026

BUY
$16.67 - $22.28 $700 - $935
42 New
42 $840,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.55B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Torren Management, LLC Portfolio

Follow Torren Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Torren Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torren Management, LLC with notifications on news.